• The power of local knowledge
    on a global scale.

    No matter where your clinical development takes you, we're already there. Where are you today?

  • We are dedicated to
    the future of clinical development
    and to every life it saves.

    Learn more about why we do what we do, and what we can do for you. Click to read our story.

Social Media

See the latest interactions from our social media


Join us at the beautiful Peninsula Hotel, Paris for an astute insight into a new era for CNS #drugdevelopment...

View Post

Featured News

Read the latest updates from our PR department

PRA Health Sciences Collaborates with AMR to Accelerate Vaccine Development

29 September 2015 Raleigh, NC – In an effort to accelerate new vaccines to market, PRA Health Sciences (PRA) is pleased to announce its collaboration with Alliance for Multispecialty...

PRA Health Sciences Looks to Expand Workforce in Pennsylvania

10 September 2015 Raleigh, NC

PRA Health Sciences (PRA) (NASDAQ: PRAH) a leading global contract research organization, is expanding its presence in Pennsylvania. Employees recently...

PRA Health Sciences, Inc. Reports Second Quarter 2015 Results and Provides Updated Guidance for 2015

  • $336.5 million of service revenue in the second quarter; 12% constant currency
    growth compared to the second quarter of 2014
  • $61.3 million of Adjusted EBITDA in the second...

Read More >

Media Resources

Explore the latest resources uploaded to our media library

Sign Up for PRA's Industry Watch

Brought to you by PRA Health Sciences. A Bi-Weekly Industry Watch Newsletter

CASE STUDY: PRA Feasibility Leads To Unique Enrollment Strategy

PRA recently performed a feasibility study to identify investigators who see patients with a rare neuromuscular autoimmune disease and who have the capability to perform a Phase II clinical trial.


PRA Health Sciences provides our clients with innovative solutions for CNS (neurology, psychiatry, and pain) drug development. Our work spans from early phase development to NDA and MAA submissions...

CASE STUDY: PRA Teamwork Demonstrates Vision

A large pharmaceutical client selected PRA to conduct 2 Phase III epilepsy studies in India, Eastern and Western Europe, and Australia. PRA’s project teams surpassed recruitment goals and achieved timely site activations despite administrative delays and tough competition for volunteers.


Find out what's happening next on PRA's event schedule

October 5 - October 8

This annual meeting began in 1998 and was the first industry-led event to complement academic-based meetings and address the specific needs of industry researchers. The program highlights current industry trends and relevant topics. The broad-based support has allowed the meeting to evolve into a premier industry-led event that is dedicated to promoting awareness of issues […]

October 5 - October 8

Translating research evidence to improve clinical practice and community resilience. Dundee University has been honoured and challenged to host the 17th International Society of Addiction Medicine (ISAM) Congress on Monday 5th to Thursday 8th October 2015. This will attract more than 100 international leading experts in the field of addiction medicine. This congress has the […]

October 8 - October 10

The Business of Pain Medicine: 21st Century Challenges & Solutions is a 3 day symposium focused on the practice of pain management with strategies to identify and overcome financial obstacles and barriers to care. Sessions will consist of lectures, break-out sessions, question and answer sessions and panel discussions. Speaker: Dr Lynn Webster (Vice President, Scientific […]

Read More >